• Lee Choong Whan’s combined holding with related parties in Samik Pharmaceutical fell to 59.44% from 60.27% as of Oct. 23, 2026.
• Reported holdings declined by 71,797 shares and stock options to 5,995,560.
• The change reflected related-party trading, stock option exercises and the removal of a retired executive’s holdings.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Samik Pharmaceutical Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261023000241), on October 23, 2026, and is solely responsible for the information contained therein.